Choate Investment Advisors Cuts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)
Choate Investment Advisors lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 49.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 606 shares of the financial services provider’s stock after selling 600 shares during the […]
More Stories
Lake Street Capital Begins Coverage on Anteris Technologies Global (NASDAQ:AVR)
Analysts at Lake Street Capital began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Get Free Report) in a...
Relx (NYSE:RELX) Now Covered by Analysts at Redburn Atlantic
Investment analysts at Redburn Atlantic assumed coverage on shares of Relx (NYSE:RELX – Get Free Report) in a research note...
Texas Roadhouse (NASDAQ:TXRH) Rating Lowered to “Hold” at Gordon Haskett
Texas Roadhouse (NASDAQ:TXRH – Get Free Report) was downgraded by analysts at Gordon Haskett from a “buy” rating to a...
The Toronto-Dominion Bank (TD) to Issue Quarterly Dividend of $1.05 on January 31st
The Toronto-Dominion Bank (TSE:TD – Get Free Report) (NYSE:TD) announced a quarterly dividend on Friday, January 10th,TickerTech Dividends reports. Investors...
West Pharmaceutical Services (NYSE:WST) Coverage Initiated by Analysts at Citigroup
Analysts at Citigroup assumed coverage on shares of West Pharmaceutical Services (NYSE:WST – Get Free Report) in a research note...
AngioDynamics (NASDAQ:ANGO) Updates FY 2025 Earnings Guidance
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share...